Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Public Policy - October, 2004
28 articles
- Glaxo Wins First Battle In Fight Against Reimportation Of Patented Drugs
- Intellectual Property Disputes Hold Up U.S.-Australian Free Trade Agreement
- FDA Calls For Uniform Name For Biogenerics
- Microsoft Lawyers Face Japanese Antitrust Panel In Dispute Over Patent Non-Assertion Clause
- Canadian Branded Drug Makers Miss R&D Target
- Swiss Activists Form Coalition To Oppose Proposed Patent Law Revisions
- Japan Bill Would Clear Way For IP Securitization
- India Government Unveils Details Of Patent Regime Overhaul
- U.S. Constitution Bars Canadian Drug Imports, Research Paper Argues
- Germany To Oppose E.U. Software Patent Proposal
- IP Courts Gaining Ground Worldwide, Survey Finds
- USPTO Vows To Hire 900 New Examiners If Congress Passes Fee Bill
- India To Overhaul Patent Regime During Parliament's Winter Session
- U.S., Israeli Negotiators Make Progress In Talks On Drug IP Rights
- Israel Provoking Global Drug Patent Dispute, E.U. Warns
- U.S. Congress Curbs Tax Breaks For IP Donations
- U.S. Anti-Piracy Crackdown To Be Modeled On Wars On Drugs, Terrorism
- Strong Job Growth In Copyright Industries, Survey Finds
- Taiwan Sends Envoy To U.S. To Discuss Removal From IP Blacklist
- U.S., Israeli Officials To Tackle Dispute Over Drug Data Exclusivity
- Hatch Eyes Generic Biologics Bill Modeled On E.U. Approach
- Induce Act Dies In Senate Committee
- Hatch, Waxman Signal Concern About "Authorized Generics"
- USTR Moves Toward Removing Taiwan From "301" IPR Watch List
- Staunch Opponent Of Software Patents Tapped To Draft E.U. Legislation
- U.S. Unveils Initiative To Crack Down On Global Piracy
- U.S. Supreme Court Mulls Rare Review Of Patent Case
- WIPO To Convene Summit To Examine Development Proposal